These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 20889924)

  • 1. C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.
    Pulikkan JA; Peramangalam PS; Dengler V; Ho PA; Preudhomme C; Meshinchi S; Christopeit M; Nibourel O; Müller-Tidow C; Bohlander SK; Tenen DG; Behre G
    Blood; 2010 Dec; 116(25):5638-49. PubMed ID: 20889924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.
    Katzerke C; Madan V; Gerloff D; Bräuer-Hartmann D; Hartmann JU; Wurm AA; Müller-Tidow C; Schnittger S; Tenen DG; Niederwieser D; Behre G
    Blood; 2013 Oct; 122(14):2433-42. PubMed ID: 23974200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.
    Pulikkan JA; Dengler V; Peramangalam PS; Peer Zada AA; Müller-Tidow C; Bohlander SK; Tenen DG; Behre G
    Blood; 2010 Mar; 115(9):1768-78. PubMed ID: 20029046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
    Wurm AA; Zjablovskaja P; Kardosova M; Gerloff D; Bräuer-Hartmann D; Katzerke C; Hartmann JU; Benoukraf T; Fricke S; Hilger N; Müller AM; Bill M; Schwind S; Tenen DG; Niederwieser D; Alberich-Jorda M; Behre G
    Nat Commun; 2017 Jun; 8(1):46. PubMed ID: 28663557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML.
    Pulikkan JA; Dengler V; Peer Zada AA; Kawasaki A; Geletu M; Pasalic Z; Bohlander SK; Ryo A; Tenen DG; Behre G
    Leukemia; 2010 May; 24(5):914-23. PubMed ID: 20376080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression.
    Kuo YY; Hou HA; Chen YK; Li LY; Chen PH; Tseng MH; Huang CF; Lee FY; Liu MC; Liu CW; Chou WC; Liu CY; Tang JL; Yao M; Tien HF
    Haematologica; 2014 Dec; 99(12):1799-807. PubMed ID: 25193961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.
    Heyes E; Schmidt L; Manhart G; Eder T; Proietti L; Grebien F
    Leukemia; 2021 Sep; 35(9):2526-2538. PubMed ID: 33623142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation.
    Rishi L; Hannon M; Salomè M; Hasemann M; Frank AK; Campos J; Timoney J; O'Connor C; Cahill MR; Porse B; Keeshan K
    Blood; 2014 Apr; 123(15):2389-400. PubMed ID: 24516045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis.
    Quintana-Bustamante O; Lan-Lan Smith S; Griessinger E; Reyal Y; Vargaftig J; Lister TA; Fitzgibbon J; Bonnet D
    Leukemia; 2012 Jul; 26(7):1537-46. PubMed ID: 22371011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Roles of CEBPA mutation and expression abnormality in acute myeloid leukemia - review].
    Wang LM; Xiao HW; Huang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1256-60. PubMed ID: 23114160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity of miR-223 regulation by CEBPA in human AML.
    Eyholzer M; Schmid S; Schardt JA; Haefliger S; Mueller BU; Pabst T
    Leuk Res; 2010 May; 34(5):672-6. PubMed ID: 20018373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia.
    Alberich-Jordà M; Wouters B; Balastik M; Shapiro-Koss C; Zhang H; Di Ruscio A; Radomska HS; Ebralidze AK; Amabile G; Ye M; Zhang J; Lowers I; Avellino R; Melnick A; Figueroa ME; Valk PJ; Delwel R; Tenen DG
    J Clin Invest; 2012 Dec; 122(12):4490-504. PubMed ID: 23160200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
    Hickey CJ; Schwind S; Radomska HS; Dorrance AM; Santhanam R; Mishra A; Wu YZ; Alachkar H; Maharry K; Nicolet D; Mrózek K; Walker A; Eiring AM; Whitman SP; Becker H; Perrotti D; Wu LC; Zhao X; Fehniger TA; Vij R; Byrd JC; Blum W; Lee LJ; Caligiuri MA; Bloomfield CD; Garzon R; Marcucci G
    Blood; 2013 Jan; 121(1):159-69. PubMed ID: 23100311
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Liu M; Du M; Yu J; Qian Z; Gao Y; Pan W; Zhao X; Wang M; Li H; Zheng J; Huang Q; Wang LM; Xiao H
    Oncoimmunology; 2022; 11(1):2016158. PubMed ID: 35003895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations.
    Volpe G; Cauchy P; Walton DS; Ward C; Blakemore D; Bayley R; Clarke ML; Schmidt L; Nerlov C; Garcia P; Dumon S; Grebien F; Frampton J
    Life Sci Alliance; 2019 Apr; 2(2):. PubMed ID: 30877232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML.
    Haefliger S; Klebig C; Schaubitzer K; Schardt J; Timchenko N; Mueller BU; Pabst T
    Blood; 2011 Jun; 117(22):5931-40. PubMed ID: 21471526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
    Pabst T; Mueller BU
    Clin Cancer Res; 2009 Sep; 15(17):5303-7. PubMed ID: 19706798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
    Pabst T; Mueller BU; Zhang P; Radomska HS; Narravula S; Schnittger S; Behre G; Hiddemann W; Tenen DG
    Nat Genet; 2001 Mar; 27(3):263-70. PubMed ID: 11242107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformation.
    Avellino R; Delwel R
    Blood; 2017 Apr; 129(15):2083-2091. PubMed ID: 28179278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.